Diagnostics & Diseases Market Research Reports & Industry Analysis

... Drive Future Growth" provides a comprehensive analysis of the various aspects such as market size of the India in-vitro diagnostics market, India immunochemistry market, ... blood gas and electrolyte market, India molecular diagnostics market, India urinalysis market and India coagulation market. The report also ...

... and development of small molecule and siRNA/miRNA inhibitors of the Pim Kinases. In addition, the report lists company-specific R&D pipelines of Pim Kinase inhibitors. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target / Mechanism of Action, Class of Compound, ...

Complete report $33,500. DataPack (test volumes, sales forecasts, supplier shares) $21,800. “2014 Opportunities in the Global Clinical Chemistry and Immunodiagnostics Markets” is a new seven-country strategic analysis of major business opportunities emerging in the clinical chemistry and immunodiagnostic ...

Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. '2014 Opportunities in the European Clinical Chemistry and Immunodiagnostics Markets' is a new five-country strategic analysis of major business opportunities emerging in the clinical chemistry and immunodiagnostic ...

... 100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. “2014 Opportunities in the French Clinical Chemistry and Immunodiagnostics Markets” is a new strategic ... the next five years. The report explores future trends in the French market; provides estimates of the specimen, test and sales volumes ...

... 100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. “2014 Opportunities in the German Clinical Chemistry and Immunodiagnostics Markets” is a new strategic ... the next five years. The report explores future trends in the German market; provides estimates of the specimen, test and sales volumes ...

Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. “2014 Opportunities in the Italian Clinical Chemistry and Immunodiagnostics Markets” is a new strategic analysis of major business opportunities emerging in the Italian clinical chemistry and immunodiagnostic markets ...

... 600. DataPack (test volumes, sales forecasts, supplier shares) $4,900. “2014 Opportunities in the Japanese Clinical Chemistry and Immunodiagnostics Markets” is a new strategic ... next five years. The report explores future trends in the Japanese market; provides estimates of the specimen, test and sales volumes ...

... 100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. “2014 Opportunities in the Spanish Clinical Chemistry and Immunodiagnostics Markets” is a new strategic ... next five years. The report explores future trends in the Spanish market; provides estimates of the specimen, test and sales volumes, ...

Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. “2014 Opportunities in the UK Clinical Chemistry and Immunodiagnostics Markets” is a new strategic analysis of major business opportunities emerging in the UK clinical chemistry and immunodiagnostic markets during the ...

Complete report $11,500. DataPack (test volumes, sales forecasts, supplier shares) $7,500 “2014 Opportunities in the US Clinical Chemistry and Immunodiagnostics Markets” is a new strategic analysis of major business opportunities emerging in the US clinical chemistry and immunodiagnostic markets during the ...

... of the therapies for Multiple Myeloma (Newly diagnosed - NDMM and relapsed/ refractory - RRMM), unmet need, and limitations of the current standard of ... care (SoC) for relapsed and refractory MM pts. The report highlights the competition and commercial opportunity ...

... antibody inhibitors of the Wnt ligand or its receptors Frizzled and LRP5/6 in oncology. In addition, the report lists company-specific R&D pipelines of Wnt pathway inhibitors. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target / Mechanism of Action, Class of ...

... market entrants identify and evaluate emerging opportunities in the European transfusion diagnostic market during the next five years, and assist industry ... and technological trends in the Europe; provides test volume and sales forecasts by market segment/test location; compares features of major automated ...

... market entrants identify and evaluate emerging opportunities in the French transfusion diagnostic market during the next five years, and assist industry ... , new product development and marketing strategies. The report explores future marketing and technological trends in France; provides test volume and sales ...

... market entrants identify and evaluate emerging opportunities in the German transfusion diagnostic market during the next five years, and assist industry ... , new product development and marketing strategies. The report explores future marketing and technological trends in Germany; provides test volume and ...

... market entrants identify and evaluate emerging opportunities in the global transfusion diagnostic market during the next five years, and assist industry ... ; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Blood ...

... market entrants identify and evaluate emerging opportunities in the Italian transfusion diagnostic market during the next five years, and assist industry ... , new product development and marketing strategies. The report explores future marketing and technological trends in Italy; provides test volume and sales ...

... market entrants identify and evaluate emerging opportunities in the Japanese transfusion diagnostic market during the next five years, and assist industry ... , new product development and marketing strategies. The report explores future marketing and technological trends in Japan; provides test volume and ...

... entrants identify and evaluate emerging opportunities in the US transfusion diagnostic market during the next five years, and assist industry executives in ... and technological trends in US; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi- ...

... has the largest share of the overall vaccines and specifically cancer vaccines market. This is followed by Europe and Asia. North America and ... process. Following parameters for each vaccine profile in development phase are covered in “Global Cancer Vaccines Pipeline Analysis” research report: Drug Profile ...

... Ingelheim's Pradaxa was not a widely held view FirstWord Pharma PLUS subscribers can view the results and analysis from this poll ... . This week's FirstWord Physician Views poll will ask: How do the clinical profiles of oral anticoagulants compare with warfarin? How does the clinical profile ...

The present Competitive Intelligence report about Bruton’s Tyrosine Kinase (BTK) Inhibitorsprovides a competitor evaluation in the field of small molecule-based inhibitors of Bruton’s Tyrosine Kinase (BTK) for the treatment of B-cell related hematologic malign ancies and autoimmune diseases as of August 2013. ...

The present Competitive Intelligence report about Focal Adhesion Kinase (FAK) Inhibitors provides a competitor evaluation in the field of small molecule-based ... and development of selective and multi-target small molecule Focal Adhesion Kinase (FAK) inhibitors in oncology. In addition, the report lists company ...

... of the disease. During the next five years, the European cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. ... Recommendations Specific new product development opportunities with potentially significant market appeal during the next five years. Design criteria for ...

... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the French cancer diagnostics ...

... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the German cancer diagnostics ...

... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer ...

... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the Italian cancer diagnostics ...

... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the Japanese cancer ...

... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the Spanish cancer diagnostics ...

... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the UK cancer ...

... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the US cancer ...

... gives you these advantages: Revenues to 2023 for IVD products at world level, with forecasting of seven submarkets - assess prospects for investments ... - explore activities, results, R&D, and outlooks for future success. In Vitro Diagnostics: World Market Outlook 2013-2023 gives independent analysis. There ...

... cells (CTCs) are believed to detach from primary or secondary tumors and enter the bloodstream, traveling to distant organs and forming new ... process of metastasis; however, their biology is still not entirely elucidated. Circulating tumor cells have tremendous utility in cancer research, aiding scientists ...

The present Competitive Intelligence report about Anaplastic Lymphoma Kinase (ALK) Inhibitors provides a competitor evaluation in the field of small molecule and antibody-based inhibitors of Anaplastic Lymphoma Kinase (ALK) for the treatment of solid tumors as of August 2013. Purchase ...

Takeda’s late stage pipeline candidate – Vortioxetine (Filed, Partnered with Lundbeck, US PDUFA on October 2nd) is expected to get ... present an attractive market for new entrants. Reported PhIII data of Vortioxetine look. However, other pipeline candidates are chasing ...

... five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and a feature ...

... five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and feature ...

The present Competitive Intelligence report about Poly-Adenyl-Ribose Polymerase (PARP) Inhibitors provides a competitor evaluation in the field of small molecule ... that repair DNA damage. Despite the recent failure of Sanofi’s PARP inhibitor iniparib, presentation of results from clinical studies with other ...

... reached USD 25 to USD 30. Therefore, there is a wide growth space for China's in-vitro diagnostics. CRI predicts that the growth rate of the ... Reagent Industry Major In-vitro Diagnostic Reagent Manufacturers in Global and China Markets Forecast on the Development of In-vitro Diagnostic Reagent Industry The ...

... when purchasing Hard Copy License depending on the location. “Ovarian Cancer Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various ... reader to identify and understand the therapeutics associated with the Ovarian Cancer disease. The information for particular drug in development process ...

... purchasing Hard Copy License depending on the location. “Pancreatic Cancer Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various ... . Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, ...

... when purchasing Hard Copy License depending on the location. “Hepatitis C Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various ... C. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, ...

... being imported raise doubts over the safety of the food available in the market. Unsafe food, which contains contaminants, may prove ... either naturally or as a result of poor production practice. According to RNCOS’ study “Global Food Safety Testing Market Analysis,” a growing number of participants in the ...

... designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies. The report provides market segmentation analysis of over ...

... designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies. The report provides market segmentation analysis of over ...

This new report from Venture Planning Group contains 800 pages, 240 tables and provides forecasts for 40 blood typing, grouping and infectious disease screening tests by country and market segment, as well as sales and market shares of leading reagent and ...

... and provides forecasts for 40 tumor markers by country and market segment, as well as sales and market shares for reagent and instrument suppliers. The report is available by region, country, section, market segment and individual test: Regions: Global, Europe Countries: France, Germany, Italy ...

... Sections: Assays, Competitors, Instrumentation, Technologies Market Segments: Home/Self Testing, Hospitals (France, Germany, Italy, Japan, Spain, UK, USA), Point-of-Care Test Groups: Diabetes/Glucose Testing, Drugs of Abuse/POC, Endocrine, Immunoproteins, Lipids, TDM, Tumor Markers/Specialty Chemistry